Whistleblower News: Cardiac Monitoring Companies To Pay More Than $44.8M To Resolve False Claims Act Liability, Advanced Bionics LLC To Pay Over $12M For Alleged False Claims For Cochlear Implant Processors, SEC Charges Former CEO Of Biotech CytoDyn

Cardiac Monitoring Companies to Pay More than $44.8 Million to Resolve False Claims Act Liability Relating to Services Performed by Offshore Technicians


BioTelemetry Inc. and its subsidiary CardioNet LLC, both headquartered in Pennsylvania (collectively “BioTelemetry”), have agreed to pay $44,875,000 to resolve allegations that they violated the False Claims Act by knowingly submitting claims to Medicare, TRICARE, the Veterans Health Administration, and the Federal Employee Health Benefits Program for heart monitoring tests that were performed, in part, outside the United States, and in many cases by technicians who were not qualified to perform such tests. read more »

Advanced Bionics LLC to Pay Over $12 Million for Alleged False Claims for Cochlear Implant Processors


Advanced Bionics LLC, a Valencia, California-based manufacturer of cochlear implant system devices, has agreed to pay more than $12 million to resolve allegations that it misled federal health care programs regarding the radio-frequency (RF) emissions generated by some of its cochlear implant processors. read more »

SEC Charges Former CEO of Biotech Company CytoDyn with Fraud, Insider Trading


The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and insider trading in connection with providing misleading information to shareholders about the progress of a clinical research treatment for COVID-19 and HIV. read more »